Holen Sie sich die Stockscreener-App
4.52
1.80%
0.08
Unicycive Therapeutics Inc Aktie (UNCY) Neueste Nachrichten
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain OfficersUNCY - PR Newswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - The AI Journal
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
UNICYCIVE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline - Morningstar
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important October 14 Deadline in Securities Fraud Lawsuit – UNCY - GlobeNewswire Inc.
Join Class Action to Recover Losses from Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Recover Investment Losses: Class Action Initiated Against Unicycive Therapeutics, Inc. (UNCY) - ACCESS Newswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
UNICYCIVE REMINDER: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire
UNCY Stockholders Have Opportunity to Lead Unicycive Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Morningstar
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
Unicycive Therapeutics' (UNCY) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Investors in Unicycive Therapeutics, Inc. Should Contact - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Unicycive Therapeutics, Inc. Investors - GlobeNewswire
Shareholders SueWallSt in New Class Action Against Unicycive Therapeutics, Inc.Act Now - Nasdaq
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire
Investors in Unicycive Therapeutics, Inc. (UNCY): Protect Your RightsContact Levi & Korsinsky Before October 14, 2025 - Newsfile
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics - GlobeNewswire
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming October - GlobeNewswire
Investor Alert: Deadline Approaching to Join Unicycive Therapeutics, Inc. (UNCY) Class ActionContact Levi & Korsinsky - Newsfile
Important Notice to Long-Term Shareholders of Humana Inc. - GlobeNewswire
Shareholders that lost money on Unicycive Therapeutics, Inc.(UNCY) Urged to Join Class ActionContact The Gross Law Firm to Learn More - Sahm
Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Contact Levi & Korsinsky Before October 14, 2025 to Join Class Action - ACCESS Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
What machine learning models say about Unicycive Therapeutics Inc.July 2025 Market Mood & Precise Buy Zone Tips - newser.com
UNCY INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - The National Law Review
Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY)Levi & Korsinsky Reminds Investors of October 14, 2025 - ACCESS Newswire
Did You Lose Money on Unicycive Therapeutics, Inc. (UNCY)? Levi & Korsinsky Urges Investors to Act Before October 14, 2025 - ACCESS Newswire
What analysts say about Unicycive Therapeutics Inc stockFundamental Stock Analysis & Small Investment Capital Tips - earlytimes.in
Unicycive Therapeutics: Interview With Founder & CEO Dr. Shalabh Gupta About The Kidney Therapy Company - Pulse 2.0
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Unicycive - GlobeNewswire
UNICYCIVE LAWSUIT ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive - MarketScreener
UNCY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Unicycive Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Press Telegram - FinancialContent
Is it too late to sell Unicycive Therapeutics Inc.July 2025 Analyst Calls & Community Trade Idea Sharing Platform - newser.com
Is Unicycive Therapeutics Inc. still worth holding after the dipJuly 2025 Patterns & Smart Swing Trading Techniques - newser.com
Advanced analytics toolkit walkthrough for Unicycive Therapeutics Inc.Quarterly Risk Review & Real-Time Chart Pattern Alerts - newser.com
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, - GuruFocus
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar
Unicycive Therapeutics, Inc. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsUNCY - MarketScreener
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Is Expected To Breakeven In The Near Future - simplywall.st
Class Action Lawsuit Filed Against Unicycive Therapeutics, Inc. (UNCY)Recover LossesContact Levi & Korsinsky Before October 14, 2025 - ACCESS Newswire
Unicycive Therapeutics, Inc. Class Action: Levi & Korsinsky - GlobeNewswire
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):